Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UWYXJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ALTA-002
|
|||||
| Synonyms |
ALTA 002; TAC002; Anti-SIRPa antibody conjugated toll-like receptor 9 agonists-ALX Oncology/Tallac Therapeutics
Click to Show/Hide
|
|||||
| Organization |
ALX Oncology, Inc.; Tallac Therapeutics, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Anti-CD47 ALTA-002 mAb
|
Antibody Info | ||||
| Antigen Name |
Leukocyte surface antigen CD47 (CD47)
|
Antigen Info | ||||
| Payload Name |
Differentiated TLR-9 agonist (T-CpG)
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 9 (TLR9)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.